JP Morgan Singular Genomics Ups IPO Target to $187M The San Diego-based DNA sequencing startup plans to offer 8.5 million shares at an IPO price between $20 and $22 per share, for a $1.5 billion valuation. Sequencing Startup Singular Genomics Files for $100M IPO The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis. Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO The firm offered 15,870,000 shares of its common stock, including 2,070,000 shares sold pursuant to the full exercise of the underwriters' option. JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More Exact Sciences discussed new Cologuard data; Danaher reviewed Cepheid's 2020 performance; and NanoString talked about forthcoming spatial biology products. JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More Qiagen's CEO discussed the company's focus on specific growth drivers, while Invitae's CEO talked about pandemic-related challenges in its genetic testing business. Jan 13, 2021 At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing Jan 12, 2021 Hologic Looks to Expand Profile in Breast Cancer Testing With Biotheranostics Acquisition Premium Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher Jan 11, 2021 PerkinElmer CEO Talks COVID-19, Long-Term Outlook at JP Morgan Dec 3, 2020 Twist Bioscience Prices Upsized $300M Public Offering Dec 2, 2020 Twist Bioscience Proposes $250M Public Offering Nov 3, 2020 Pacific Biosciences Gears Up For Commercial, R&D Push With Eye Toward Collaborations Premium Oct 14, 2020 JP Morgan Rates Invitae Neutral Oct 8, 2020 NanoString Technologies Prices $200M Public Offering Oct 7, 2020 NanoString Technologies Q3 Preliminary Product, Service Revenues Grow 14 Percent Oct 2, 2020 Pacific Biosciences Upgraded to Overweight by JP Morgan Sep 21, 2020 Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider Premium Sep 21, 2020 JP Morgan Downgrades Illumina to Neutral on Grail Deal Sep 11, 2020 10x Genomics Prices Upsized $440M Public Offering Sep 9, 2020 10x Genomics to Sell 3.5M Shares in Public Offering Aug 20, 2020 JP Morgan Assigns Overweight Ratings to Thermo Fisher, Qiagen Aug 11, 2020 JP Morgan, Cowen, William Blair Initiate Coverage of Berkeley Lights Jul 17, 2020 Berkeley Lights Prices Upsized $178.2M IPO Jul 16, 2020 Adaptive Biotechnologies to Raise $240M in Public Stock Offering Jun 4, 2020 Twist Bioscience Prices $100M Stock Offering Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.